Real-World Effectiveness in Biologics for CRSwNP

Chronic rhinosinusitis with nasal polyps (CRSwNP) remains a challenging condition, and biologic therapies are transforming patient outcomes. This live masterclass will provide an up-to-date overview of the latest real-world evidence (RWE) data on three key biologics in CRSwNP as of 2025.

Participants will:

• Gain insights into the current efficacy and safety data from real-world practice.
• Learn how to critically interpret the strengths and limitations of RWE compared to clinical trial data.
• Explore practical guidance on patient and treatment selection to optimise outcomes in CRSwNP and nasal polyp syndrome.

Designed for ENT specialists, allergists, pulmonologists, and all clinicians managing CRSwNP, this session will combine evidence-based updates with expert perspectives to support confident, individualised treatment decisions.

This masterclass is positioned for CME-accreditation.

Registration coming soon!